A 1707

  • New York Assembly Bill
  • 2023 Regular Session
  • Introduced in Assembly
  • Passed Assembly Jun 06, 2023
  • Passed Senate Jun 06, 2023
  • Signed by Governor Dec 22, 2023

Requires certain manufacturers of prescription drugs to notify the drug utilization review board of the proposed increase of the wholesale acquisition cost of such prescription drugs

Abstract

Requires certain manufacturers of prescription drugs to notify the superintendent of any proposed increase of the wholesale acquisition cost of such prescription drugs.

Bill Sponsors (31)

Votes


Actions


Dec 22, 2023

Assembly

SIGNED CHAP.738

Dec 12, 2023

Assembly

DELIVERED TO GOVERNOR

Jun 06, 2023

Assembly

PASSED ASSEMBLY

Assembly

DELIVERED TO SENATE

Senate

REFERRED TO RULES

Senate

SUBSTITUTED FOR S599A

Senate

3RD READING CAL.75

Senate

PASSED SENATE

Senate

RETURNED TO ASSEMBLY

May 30, 2023

Assembly

AMENDED ON THIRD READING 1707A

Assembly

RESTORED TO THIRD READING

Assembly

SUBSTITUTION RECONSIDERED

May 15, 2023

Assembly

SUBSTITUTED BY S599

May 11, 2023

Assembly

ADVANCED TO THIRD READING CAL.196

May 09, 2023

Assembly

REPORTED

Apr 26, 2023

Assembly

REPORTED REFERRED TO CODES

Feb 08, 2023

Assembly

REFERENCE CHANGED TO INSURANCE

Jan 18, 2023

Assembly

REFERRED TO HEALTH

Bill Text

Bill Text Versions Format
A1707 PDF HTML
A1707A PDF

Related Documents

Document Format
No related documents.

Sources

Data on Open States is updated periodically throughout the day from the official website of the New York Legislature.

If you notice any inconsistencies with these official sources, feel free to file an issue.